Data from the trial, which enrolled 19 patients, indicate that Gvax immunotherapy results in a statistically significant increase in median PSA (prostate-specific antigen) doubling time as well as
Pediatrix paid cash for the practice, which is expected to contribute immediately to earnings per share. The practice was founded in 2002 by Raul Aguirre, who has more
Novelos has sold 113.5 shares of series D convertible preferred stock, having a stated value equal to $50,000 per share, a cumulative annual dividend of 9% of stated
The company plans to break ground in 2009 with the plant being fully functional in 2012. The company is expected to employ more than 150 employees within three
The first project is currently filed and pending FDA approval. The companies plan to file an abbreviated new drug application (ANDA) with the FDA for the second product
The patent also covers the measurement of the new modifications of brain natriuretic peptide by a variety of methods, including SELDI (surface enhanced laser desorption/ionization) mass spectrometry –
Prior to joining AdnaGen, Dr Rodatz was general manager of Digilab BioVisioN, a Germany company offering technologies for peptide and protein biomarker discovery as well as sample preparation
Orphan designation will provide amrubicin with 10 years of marketing exclusivity following marketing approval for the treatment of small cell lung cancer. Orphan medicinal product designation is granted
The study also discovered that overall 3% of all admitted under Medicare during 2004-06 period were injured — largely as a result of medical mistakes, including prescribing errors.
In its response to the European Commission’s public consultation on the prescription drug information, the European Federation of Pharmaceutical Industries and Associations (EFPIA) emphasized the need for a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.